Pizzuti Dana sold CRNX
January 3, 2024 · Form 4 insider transaction
Pizzuti Dana sold 14,375 shares of Crinetics Pharmaceuticals, Inc. at $35.00 per share, a transaction worth $503.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan.; The common stock was sold by the Reporting Person in open market transactions on the transaction date with a volume weighted average sales price of $35.00 per share. The range of sales prices on the transaction date was $34.82 to $35.32 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.